AstraZeneca (AZN) RNS Announcements

Add to Alert list
Date Time Source Announcement
26 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
25 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
24 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
23 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
22 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
19 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
18 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
17 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
16 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
15 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
12 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
10 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
08 Sep 2003 04:00 PM
RNS
Director Shareholding
08 Sep 2003 07:00 AM
RNS
Symbicort
04 Sep 2003 05:15 PM
RNS
Director Shareholding
04 Sep 2003 07:00 AM
RNS
Purchase of Own Securities
01 Sep 2003 07:54 AM
RNS
Exanta Study
01 Sep 2003 07:01 AM
RNS
Atacand CHARM Study
27 Aug 2003 03:00 PM
RNS
Capital Group
13 Aug 2003 07:01 AM
RNS
Crestor
08 Aug 2003 01:30 PM
RNS
Patent Infringement - Mylan
24 Jul 2003 11:00 AM
RNS
Interim Results - part 2 0f 2
24 Jul 2003 11:00 AM
RNS
Interim Results - part 1of 2
23 Jul 2003 09:00 AM
RNS
Notice of Results
14 Jul 2003 11:15 AM
RNS
Exanta
10 Jul 2003 07:00 AM
RNS
Crestor
08 Jul 2003 04:00 PM
RNS
Director Shareholding
01 Jul 2003 01:30 PM
RNS
New Appointments
23 Jun 2003 09:36 AM
RNS
Exanta
23 Jun 2003 07:37 AM
RNS
Statement re Zoladex
02 Jun 2003 07:00 AM
RNS
Purchase of Own Securities
30 May 2003 07:00 AM
RNS
Purchase of Own Securities
28 May 2003 07:00 AM
RNS
Purchase of Own Securities
22 May 2003 07:00 AM
RNS
Purchase of Own Securities
21 May 2003 07:00 AM
RNS
Purchase of Own Securities
20 May 2003 07:01 AM
RNS
Crestor
20 May 2003 07:00 AM
RNS
Purchase of Own Securities
19 May 2003 12:00 PM
RNS
Director Shareholding
19 May 2003 07:00 AM
RNS
Purchase of Own Securities
15 May 2003 12:00 PM
RNS
Director Shareholding
13 May 2003 07:00 AM
RNS
Purchase of Own Securities
08 May 2003 03:00 PM
RNS
Capital Group
08 May 2003 07:00 AM
RNS
Purchase of Own Securities
06 May 2003 04:00 PM
RNS
Capital Group
06 May 2003 07:00 AM
RNS
Iressa
02 May 2003 11:59 AM
RNS
AGM Resolutiions
30 Apr 2003 04:24 PM
RNS
AGM Poll Votes
30 Apr 2003 11:00 AM
RNS
Directorate Change
30 Apr 2003 10:00 AM
RNS
1st Quarter Results
30 Apr 2003 10:00 AM
RNS
1st Quarter Results

AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.

It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.

Astra Zeneca share price launched at 605p in 1993.

UK 100

Latest directors dealings